Emili Torrell Cortada
Corporate Officer/Principal at ORYZON GENOMICS S.A.
Profile
Emili Torrell Cortada is currently the Chief Business Development Officer at Oryzon Genomics SA since 2007.
Previously, he worked as the Marketing Director at Almirall SA from 2010 to 2014.
He also held the position of Manager-International Product at Prodesfarma SA and Senior Licensing Manager at Esteve Pharmaceuticals S.A.
Mr. Torrell Cortada completed his undergraduate and graduate degrees at the University of Barcelona.
He also holds an MBA from the Escuela Superior de Administración y Dirección de Empresas.
Emili Torrell Cortada active positions
Companies | Position | Start |
---|---|---|
ORYZON GENOMICS S.A. | Corporate Officer/Principal | 2007-01-31 |
Former positions of Emili Torrell Cortada
Companies | Position | End |
---|---|---|
Prodesfarma SA | Corporate Officer/Principal | - |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Corporate Officer/Principal | - |
ALMIRALL, S.A. | Sales & Marketing | - |
Training of Emili Torrell Cortada
University of Barcelona | Graduate Degree |
Escuela Superior de Administración y Dirección de Empresas | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ALMIRALL, S.A. | Health Technology |
ORYZON GENOMICS S.A. | Health Technology |
Private companies | 2 |
---|---|
Prodesfarma SA | |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
- Stock Market
- Insiders
- Emili Torrell Cortada